» Articles » PMID: 35431318

Functionalized Graphene Oxide in Microbial Engineering: An Effective Stimulator for Bacterial Growth

Overview
Journal Carbon N Y
Date 2022 Apr 18
PMID 35431318
Authors
Affiliations
Soon will be listed here.
Abstract

Whether graphene and graphene oxide (GO) would affect the activities of bacteria has been under debate. Nevertheless, how graphene derivatives with biocompatible coatings interact with microorganisms and the underlying mechanisms are important issues for nanobiotechnology, and remain to be further explored. Herein, three new types of nano-GOs functionalized with polyethylene glycol (nGO-PEGs) were synthesized by varying the PEGylation degree, and their effects on were carefully investigated. Interestingly, nGO-PEG (1:1), the one with relatively lower PEGylation degree, could significantly stimulate bacterial growth, whereas as-made GO and the other two nGO-PEGs showed no effect. Further analysis revealed that nGO-PEG (1:1) treatment significantly accelerated FtsZ-ring assembly, shortening Phase 1 in the bacterial cell cycle. Both DNA synthesis and extracellular polymeric substance (EPS) secretion were also dramatically increased. This unique phenomenon suggests promising potentials in microbial engineering as well as in clinical detection of bacterial pathogens. As a proof-of-concept, nGO-PEG (1:1) treatment could remarkably enhance (up to 6-fold) recombinant protein production in engineered bacteria cells. To our best knowledge, this is the first demonstration of functionalized GO as a novel, positive regulator in microbial engineering. Moreover, our work highlights the critical role of surface chemistry in modulating the interactions between nanomaterials and microorganisms.

Citing Articles

Graphene-based nanomaterials for cancer therapy and anti-infections.

Wang Y, Li J, Li X, Shi J, Jiang Z, Zhang C Bioact Mater. 2022; 14:335-349.

PMID: 35386816 PMC: 8964986. DOI: 10.1016/j.bioactmat.2022.01.045.


Photothermal-assisted antibacterial application of graphene oxide-Ag nanocomposites against clinically isolated multi-drug resistant .

Chen Y, Wu W, Xu Z, Jiang C, Han S, Ruan J R Soc Open Sci. 2020; 7(7):192019.

PMID: 32874607 PMC: 7428222. DOI: 10.1098/rsos.192019.


Medium-Dependent Antibacterial Properties and Bacterial Filtration Ability of Reduced Graphene Oxide.

Gusev A, Zakharova O, Muratov D, Vorobeva N, Sarker M, Rybkin I Nanomaterials (Basel). 2019; 9(10).

PMID: 31614934 PMC: 6835404. DOI: 10.3390/nano9101454.

References
1.
Liu X, Liu L, Wang Y, Wang X, Ma Y, Li Y . The Study on the factors affecting transformation efficiency of E. coli competent cells. Pak J Pharm Sci. 2014; 27(3 Suppl):679-84. View

2.
Liu M, Song J, Shuang S, Dong C, Brennan J, Li Y . A graphene-based biosensing platform based on the release of DNA probes and rolling circle amplification. ACS Nano. 2014; 8(6):5564-73. DOI: 10.1021/nn5007418. View

3.
Ma J, Drake P, Christou P . The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet. 2003; 4(10):794-805. DOI: 10.1038/nrg1177. View

4.
Zhang L, Lu Z, Zhao Q, Huang J, Shen H, Zhang Z . Enhanced chemotherapy efficacy by sequential delivery of siRNA and anticancer drugs using PEI-grafted graphene oxide. Small. 2011; 7(4):460-4. DOI: 10.1002/smll.201001522. View

5.
Zhang L, Xia J, Zhao Q, Liu L, Zhang Z . Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2009; 6(4):537-44. DOI: 10.1002/smll.200901680. View